S. A. A. Mamun, R. Jahan, Q. T. Islam, T. Nazrin, and K. Shajalal, “Rationale of Using Common Antifibrotic Therapy in Post COVID Fibrosis”, J. Medicine, vol. 22, no. 1, pp. 46–50, Jan. 2021.